Mar 18, 2025
TAIPEI,March 18,2025-- The widely acclaimed Optoma Management Suite (OMS),an innovative display device management system highly praised by IT administrators,has undergone a comprehensive upgrade in 20
The Excitement Reaches New Heights HONG KONG,Feb. 14,2025-- Following the success of round one lucky draw,AsiaWorld-Expo (AWE) proudly announces the launch of the "AWE Mega Event Lucky Draw – Ro
Feb 17, 2025
Earnings Call Scheduled for 7:00 A.M. U.S. ET on March 5,2025 GUIYANG,China,Feb. 14,2025-- Full Truck Alliance Co. Ltd. ("FTA" or the "Company") (NYSE: YMM),a leading digital freig
Feb 17, 2025
HANGZHOU,China,Feb. 14,2025-- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK),the world\'s leading premium new energy vehicle group,today a
Feb 17, 2025
SINGAPORE,Feb. 14,2025-- ATxEnterprise (ATxE) 2025,a flagship event of Asia Tech x Singapore (ATxSG),returns for its fifth year,providing a strategic platform for enterprises,governments,and technolo
Feb 17, 2025
SUZHOU,China,Feb. 13,2025-- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-306) of anti-HER2 bi
Feb 14, 2025
The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial.
Feb 14, 2025